Hims
Hims is a personal health care made by Hims Hers Health Inc. Class A.
About
Hims is a telehealth service aimed at men, made by Hims and Hers Health (HIMS), that connects customers to licensed clinicians who can prescribe treatments, with prescriptions fulfilled through licensed pharmacies. The company launched in 2017 and is based in San Francisco. Hims covers hair loss, sexual health, low testosterone, weight loss, mental health and skin care, and Hers is the company's sister brand.
Key facts
- Type
- Product
- Category
- Personal health care
- Made by
- Hims Hers Health Inc. Class A
- Also known as
- Hims Health, Hims for Men
What is being said
Sentiment on Hims is neutral over the past month and strengthening from a month ago; there is no reading for today yet. Most of the conversation is on News, X and App Store.
X and YouTube lean bullish, Reddit leans neutral, News and App Store lean bearish.
What is driving the conversation about Hims
Connections of Hims
At Hims Hers Health Inc. Class A
Peers of Hims Hers Health Inc. Class A
Frequently asked questions
Who makes Hims?
Hims is made by Hims Hers Health Inc. Class A.
Is sentiment on Hims bullish or bearish right now?
Sentiment on Hims is neutral over the past month on SentiSense. There is no reading for today yet. SentiSense tracks it daily with the SentiSense Score, shown on this page for signed-in readers.
What is driving attention to Hims?
Recent stories driving the conversation include "Hims & Hers Closes Up 10% on Peptide Rules Report as Citi Keeps Sell and $25 Target" (October 9, 2026).
See the live SentiSense Score, mentions and source mix on this page after you sign in, free.
Educational only, not investment advice.